Published: Jan. 1, 2024
Language: Английский
Published: Jan. 1, 2024
Language: Английский
Analytical Chemistry, Journal Year: 2024, Volume and Issue: 96(8), P. 3436 - 3444
Published: Feb. 19, 2024
Cerebral ischemia–reperfusion injury (CIRI), a cause of cerebral dysfunction during infarction treatment, is closely associated with mitochondrial viscosity and hydrogen peroxide (H2O2). However, the accurate measurement H2O2 levels in CIRI challenging because lack sufficient selectivity blood–brain barrier (BBB) penetration existing monitoring tools related to CIRI, hampering exploration role CIRI. To address this issue, we designed an activatable fluorescent probe, mitochondria-targeting styryl-quinolin-ium (Mito-IQS), excellent properties including high selectivity, targeting, BBB penetration, for visualization brain. Based on real-time capabilities bursts were visualized This probe can be used monitor therapeutic effects butylphthalein treatment. More importantly, vivo experiments further confirmed that was levels. discovery provides new insights study expected accelerate process diagnosis, drug design.
Language: Английский
Citations
22TrAC Trends in Analytical Chemistry, Journal Year: 2024, Volume and Issue: 174, P. 117684 - 117684
Published: April 2, 2024
Language: Английский
Citations
9Sensors and Actuators B Chemical, Journal Year: 2024, Volume and Issue: 418, P. 136151 - 136151
Published: July 4, 2024
Language: Английский
Citations
7Sensors and Actuators B Chemical, Journal Year: 2024, Volume and Issue: 410, P. 135646 - 135646
Published: March 16, 2024
Language: Английский
Citations
4Sensors and Actuators B Chemical, Journal Year: 2024, Volume and Issue: 419, P. 136419 - 136419
Published: Aug. 4, 2024
Language: Английский
Citations
3Published: Jan. 1, 2025
Glioblastoma (GBM) is one of the most aggressive and deadly cancers. Due to complexity redundancy within signaling networks in GBM, targeted inhibitors specific pathways have shown only limited success. The nuclear export receptor Chromosome Region Maintenance 1 (CRM1) has recently emerged as a promising therapeutic target, its inhibition can simultaneously disrupt multiple key oncogenic drivers. In this study, we explore whether chromenone derivatives, known for detecting thiol-containing molecules, function CRM1 inhibitors. We synthesized several chromenone-based derivatives demonstrated that they inhibit CRM1-driven structure- dose-dependent manner. A preliminary structure-activity relationship (SAR) was established, providing rationale selective binding based on molecular docking studies. Additionally, showed active effectively endogenous signal (NES)-containing substrates glioblastoma cells. Several these compounds exhibit cytotoxicity against cell lines, highlighting their potential therapies GBM.
Language: Английский
Citations
0Talanta, Journal Year: 2025, Volume and Issue: 295, P. 128362 - 128362
Published: May 21, 2025
Language: Английский
Citations
0Food Chemistry, Journal Year: 2025, Volume and Issue: 489, P. 144998 - 144998
Published: June 3, 2025
Language: Английский
Citations
0Published: May 14, 2024
Language: Английский
Citations
1Microchemical Journal, Journal Year: 2024, Volume and Issue: unknown, P. 111742 - 111742
Published: Sept. 1, 2024
Language: Английский
Citations
1